Product Reports Resources Pricing Login Book a demo

Shanghai Yiru Biotechnology

Biotech & Life Sciences · China · Founded 2021

Sustainable biomaterials developed via synthetic biology methods MoreLess

Shanghai Yiru Biotechnology Co., Ltd., operating as SynMetabio, was founded in 2021 and is headquartered in Shanghai, China. The company develops next-generation sustainable biomaterials by integrating biotechnology with materials modification science. SynMetabio leverages synthetic biology, including gene editing and precision fermentation, to create novel bio-based materials from recycled biomass waste like discarded fruit and straw. These materials are designed to offer unique visual textures, scents, and tactile qualities.

The company's product line includes bio-based leather, mycelium-based materials, and other biomaterials. These products serve a wide range of industries, including fashion, furniture, and automotive. For example, the firm has developed a bio-based leather called Naro and has partnered with Anta to create sneakers from mycelium material. In a collaboration with Dole, SynMetabio is converting waste fruit into 100% bio-based materials using mycelium.

The company was founded by Su Rui, who, as an undergraduate at ShanghaiTech University, developed an interest in the intersection of biology and materials science. SynMetabio has received funding from investors such as Miracleplus, Linear Capital, Danen Capital, and K2VC. With a research and development center of nearly 2,000 square meters, the company has established a platform for the development and pilot production of microbial fiber materials.

Keywords: synthetic biology, biomaterials, sustainable materials, precision fermentation, mycelium, bio-based leather, material innovation, circular economy, biotech, cleantech, material science, biomass waste recycling, sustainable fashion, alternative materials, biofabrication, bioplastics, gene editing, microbial materials, protein design, green technology

Company overview

Shanghai Yiru Biotechnology company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2021
Headquarters
China
Employees
2
Open positions
None listed
Dealroom signal
25.7
client focusb2btechnologyDeep Techsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiomaterialssectorSynthetic BiologysectorSustainable Development GoalssectorAdvanced MaterialssectorClimate TechsectorCircular Economysectorprecision fermentationindustryChemicals

Valuation & funding

Shanghai Yiru Biotechnology funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Jul 2026 $14M $55M Chaosheng Capital · Hedera Finances · Ordos Group
SEEDEquity / VC Apr 2024 $2.8M $14M MiraclePlus · Star Capital · Linear · Danen Capital
SEEDEquity / VC Mar 2023 $2.8M $11M K2VC · Linear Capital · MiraclePlus · Danen Capital
Showing 3 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 2
2025 2
2024 2
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Shanghai Yiru Biotechnology website traffic

Latest recorded traffic for Shanghai Yiru Biotechnology is 80 monthly website visits, down 87.9% over the last three months. Shanghai Yiru Biotechnology's team grew 0% over the past year.

Latest monthly visits80 3-month web change-87.9% 1-year team growth0%
Monthly website visits6 observations · Mar 2024–Nov 2025
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Shanghai Yiru Biotechnology compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Shanghai Yiru Biotechnology's talent

Book a demo to see the people
Employees 2 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

9 investors on Shanghai Yiru Biotechnology's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 6 investors entered at this stage
Linear Capital
MiraclePlus
K2VC
Danen Capital
Star Capital
Linear
Series A 3 investors entered at this stage
Hedera Finances
Ordos Group
Chaosheng Capital

Global footprint

Where Shanghai Yiru Biotechnology has talent and traffic

Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

In the news

Latest news about Shanghai Yiru Biotechnology

Recent press, funding announcements, and product moves mentioning Shanghai Yiru Biotechnology — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Shanghai Yiru Biotechnology

An AI-synthesized read of the highest-engagement posts about Shanghai Yiru Biotechnology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Yiru Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.